Comment Sought by IP Australia on Patentability of Isolated Genetic Material
Following the decision in D’Arcy v Myriad Genetics Inc (“D’Arcy”), in which the High Court of Australia unanimously decided that claims to isolated nucleic acids represent information coding for a polypeptide and as such do not define a ‘manner of manufacture’ (and are therefore not patent eligible), IP Australia now have issued their proposed practice …
>> Read more